Gérard Bastian

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer

G. Metzger, Claire Massari, Marie‐Christine Etienne et al. · Clinical Pharmacology & Therapeutics · 1994 · 68 citations

Comparative serum protein binding of anthracycline derivatives

Olivier Chassany, Saı̈k Urien, Pascal Claudepierre et al. · Cancer Chemotherapy and Pharmacology · 1996 · 49 citations

Biochemistry, Peptide Library, Bioconjugation +2

Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy

Yvan Canitrot, Francis Bichat, Susan P.C. Cole et al. · Cancer Letters · 1998 · 26 citations

Tumor Biology, Mdr1 Expression, Medicine +9

Clinical trial and pharmacokinetics of carboplatin 560 mg/m² in children

François Doz, Laurence Brugières, Gérard Bastian et al. · Medical and Pediatric Oncology · 1990 · 15 citations

Translational Medicine, Oncology, Carboplatin 560 +14

Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning technique

Gérard Bastian, Catherine Lucas, Jean-Pierre Bizzari et al. · Investigational New Drugs · 1992 · 12 citations

Thrombopoiesis, Biochemistry, Erythrocyte Partitioning Technique +9